IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $9,000 | -93.6% | 656 | -89.0% | 0.00% | -100.0% |
Q3 2016 | $141,000 | +370.0% | 5,938 | +477.1% | 0.00% | – |
Q2 2016 | $30,000 | -79.5% | 1,029 | -77.4% | 0.00% | -100.0% |
Q1 2016 | $146,000 | -77.6% | 4,549 | -70.2% | 0.00% | -83.3% |
Q4 2015 | $652,000 | -45.1% | 15,241 | -54.8% | 0.01% | -50.0% |
Q3 2015 | $1,187,000 | -57.9% | 33,716 | -45.1% | 0.02% | -33.3% |
Q2 2015 | $2,820,000 | +56.3% | 61,422 | +59.6% | 0.04% | +56.5% |
Q1 2015 | $1,804,000 | -29.4% | 38,488 | -52.3% | 0.02% | -23.3% |
Q4 2014 | $2,556,000 | +96.8% | 80,667 | +47.2% | 0.03% | -33.3% |
Q3 2014 | $1,299,000 | -26.8% | 54,788 | -7.4% | 0.04% | +125.0% |
Q2 2014 | $1,775,000 | – | 59,192 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |